Vitreous.aemorrhage by itself usually doesn’t cause permanent vision loss. Diabetic retinopathy is a deterioration of the blood vessels in the retina that usually affects both eyes. Gardner, M.D., M.S., studies the effects of diabetes on the retina. Prognosis depends upon the extent of the retinopathy, the cause, and promptness of treatment. Treatment depends on the cause of the disease. However, patients need to be aware if any medication they are taking will affect the eyes. It can even cause legal blindness . They may also use fluoresce in angiography, which involves injecting a dye into a vein of the arm and taking a series of retinal photos to detect signs of leaky blood vessels.
It may be discovered during a routine eye exam. The retina of a person with diabetic retinopathy and DBE, as viewed by optical coherence tomography OCR. The better you control blood sugar levels, the lower your risk. In more advanced cases, treatment is recommended to stop the damage of diabetic retinopathy, prevent vision loss, and potentially restore vision. The blood often clears from the eye within a few weeks or months. Annual eye exams are crucial for people with diabetes. Diagnosing retinopathy begins with taking a thorough personal and family medical history, including symptoms, and completing a physical examination, including an extensive eye examination. And this is the most common retinopathy. It is important to take action before you notice any eye problems. The longer a person has diabetes or hypertension, the more likely a person will develop retinopathy. Eventually, it can cause blindness. Scatter laser surgery works best before new, fragile blood vessels have started to bleed. Glaucoma is a group of diseases that damage the eye’s optic nerve—the bundle of nerve fibbers that connects the eye to the brain. It is the most common cause of vision loss among people with diabetes and the leading cause of vision impairment and blindness among working-age adults.
The finding was the first major treatment advance for proliferative diabetic retinopathy in 40 years . In 2016, the DRCR.net reported results of a clinical trial that compared three anti-VEGF drugs for diabetic macular edema, a complication of diabetic retinopathy that causes the build-up of fluid in a region of the retina called the macula. The study found that Lucentis, Avastin (bevacizumab), and Eylea (aflibercept) were similarly effective when patients vision loss was mild. Eylea outperformed Avastin and Lucentis among patients who started treatment with moderate (20/50) or worse vision. There has never been a more hopeful time in the treatment of diabetic retinopathy, said Dr. http://advisingeyesurgeon.beatthetrain.org/2016/12/05/getting-advice-on-swift-products-in-eye-surgery/Huang, a member of the DRCR.net. Dr. Huang is also chair of the Diabetic Eye Disease Subcommittee for NEIs National Eye Health Education Program. Resources The National Eye Health Education Program has materials and information for National Diabetes Month at https://nei.nih.gov/nehep/ndm . The NEI provides details about diabetic eye disease including diabetic retinopathy at http://www.nei.nih.gov/health/diabetic/ .
For the original version including any supplementary images or video, visit <a href='http://www.newswise.com/articles/view/665152/?The Top Information On Choosing Critical Criteria Of Eye Bags | Suggestions For The Eyeballssc=rsmn’ rel=’nofollow’>http://www.newswise.com/articles/view/665152/?sc=rsmn